US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Fox News senior medical analyst Dr. Marc Siegel reflects on his interview with NIH Director Dr. Jay Bhattacharya addressing ...

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...